A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim /Puregon ) in healthy female volunteers

This publication has 19 references indexed in Scilit:

• Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon®) by Pen-injector and syringe
  Human Reproduction, 1999
• Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations
  Human Reproduction, 1997
• Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins
  Human Reproduction, 1997
• A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin
  Human Reproduction, 1996
• Retrospective analysis of subcutaneous administration of urinary gonadotrophins inin vitrofertilisation
  Journal of Obstetrics and Gynaecology, 1996
• Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration
  Acta Endocrinologica, 1994
• Self‐administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism
  Clinical Endocrinology, 1993
• International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and Standards
  Drug Information Journal, 1991
• Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal Products
  Basic & Clinical Pharmacology & Toxicology, 1990
• Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH
  Contraception, 1976